VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 70 filers reported holding VOYAGER THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,346,476 | -30.8% | 302,771 | +2.2% | 0.00% | -100.0% |
| Q2 2023 | $3,390,574 | +411.4% | 296,120 | +244.4% | 0.00% | – |
| Q1 2023 | $662,960 | +30.0% | 85,987 | +2.8% | 0.00% | – |
| Q4 2022 | $510,009 | +11.8% | 83,608 | +8.6% | 0.00% | – |
| Q3 2022 | $456,000 | +3.2% | 77,000 | +2.9% | 0.00% | – |
| Q2 2022 | $442,000 | -26.7% | 74,808 | -5.4% | 0.00% | – |
| Q1 2022 | $603,000 | +188.5% | 79,119 | +2.2% | 0.00% | – |
| Q4 2021 | $209,000 | +6.1% | 77,436 | +3.5% | 0.00% | – |
| Q3 2021 | $197,000 | -43.4% | 74,783 | -11.3% | 0.00% | – |
| Q2 2021 | $348,000 | -76.4% | 84,295 | -73.1% | 0.00% | – |
| Q1 2021 | $1,474,000 | -41.7% | 312,956 | -11.5% | 0.00% | – |
| Q4 2020 | $2,528,000 | -34.5% | 353,427 | -2.4% | 0.00% | -100.0% |
| Q3 2020 | $3,862,000 | -18.8% | 362,003 | -3.9% | 0.00% | 0.0% |
| Q2 2020 | $4,755,000 | +51.0% | 376,739 | +9.4% | 0.00% | 0.0% |
| Q1 2020 | $3,149,000 | -32.8% | 344,231 | +2.5% | 0.00% | 0.0% |
| Q4 2019 | $4,685,000 | -19.0% | 335,858 | -0.1% | 0.00% | 0.0% |
| Q3 2019 | $5,783,000 | -28.2% | 336,053 | +13.6% | 0.00% | -50.0% |
| Q2 2019 | $8,055,000 | +49.9% | 295,927 | +5.4% | 0.00% | +100.0% |
| Q1 2019 | $5,374,000 | +107.9% | 280,752 | +2.1% | 0.00% | 0.0% |
| Q4 2018 | $2,585,000 | -52.0% | 275,040 | -3.5% | 0.00% | 0.0% |
| Q3 2018 | $5,391,000 | +3.2% | 284,985 | +6.6% | 0.00% | 0.0% |
| Q2 2018 | $5,226,000 | +38.8% | 267,441 | +33.5% | 0.00% | 0.0% |
| Q1 2018 | $3,765,000 | +16.9% | 200,378 | +3.2% | 0.00% | 0.0% |
| Q4 2017 | $3,221,000 | +1.9% | 194,102 | +26.5% | 0.00% | 0.0% |
| Q3 2017 | $3,160,000 | +164.0% | 153,496 | +14.9% | 0.00% | – |
| Q2 2017 | $1,197,000 | -14.2% | 133,571 | +26.8% | 0.00% | – |
| Q1 2017 | $1,395,000 | +3.6% | 105,349 | -0.4% | 0.00% | – |
| Q4 2016 | $1,347,000 | +6.3% | 105,757 | +0.2% | 0.00% | – |
| Q3 2016 | $1,267,000 | +9.1% | 105,537 | -0.2% | 0.00% | – |
| Q2 2016 | $1,161,000 | +141.9% | 105,703 | +92.2% | 0.00% | – |
| Q1 2016 | $480,000 | -60.1% | 54,990 | 0.0% | 0.00% | – |
| Q4 2015 | $1,204,000 | – | 54,990 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
| ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
| Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
| BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
| Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
| GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
| Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
| HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
| Birchview Capital, LP | 33,000 | $310,000 | 0.29% |